We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu

PinPointe FootLaser for the Treatment of Onychomycosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00935649
Recruitment Status : Completed
First Posted : July 9, 2009
Results First Posted : April 9, 2013
Last Update Posted : April 9, 2013
Information provided by:
PathoLase, Inc.

Brief Summary:
To evaluate the safety and efficacy of the PathoLase FootLaser treatment of infected toenails.

Condition or disease Intervention/treatment Phase
Infected Toenails Onychomycosis Device: PinPointe FootLaser Phase 2 Phase 3

Detailed Description:
The study is a multi-center controlled study evaluating laser treatments of infected great toes in a randomized blinded study of approximately 125 subjects. Right and left great toes are randomized to treatment or no treatment. Samples from infected areas are sampled and evaluated for presence of fungus with KOH, PCR and culture tests. Nail bed clearing and nail plate growth are measured from high resolution photographs by a blinded evaluator. Subjects will be evaluated at baseline and at 8, 16, 24 and 48 weeks for safety and effectiveness of study treatment.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 134 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Multi-Center Trial: Evaluation of PinPointe FootLaser Treatment for Infected Toenails (Onychomycosis)
Study Start Date : June 2009
Actual Primary Completion Date : November 2010
Actual Study Completion Date : November 2010

Arm Intervention/treatment
Experimental: Randomized great toe
Subjects with both great toes infected. Right/left randomized to treatment / no treatment
Device: PinPointe FootLaser
Medical laser

No Intervention: Untreated Toe

Primary Outcome Measures :
  1. Nail Bed Clearing [ Time Frame: 48 weeks ]
    Change in amount of clear nail over time.

Secondary Outcome Measures :
  1. Mycology [ Time Frame: 48 weeks ]
    KOH, PCR and cultures of patients who were bilaterally positive or negative for each test.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Volunteers of either sex,
  • 18-80 years of age,
  • Both great toes with clinical signs of infection.
  • Positive KOH or culture test

Exclusion Criteria:

  • Existing or history of cancer/skin malignancy,
  • Use of oral antifungal agents in past 6 months,
  • Use of topical antifungal agents in past 1 month,
  • Loss of protective sensation in either foot,
  • Infection involving lunula of either great toe,
  • Longitudinal streaks/spikes of either great toenail,
  • Distal nail thickness > 2 mm of either great toe,
  • Prior surgical treatment of either great toe in past 12 months,
  • Participation in another medical device/pharmaceutical study,
  • Condition that investigator determines makes it unsafe for subject to participate,
  • Pregnancy, breastfeeding or plans to become pregnant.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00935649

Layout table for location information
United States, New York
Rochester Laser Center
Rochester, New York, United States, 14617
United States, Texas
Endeavor Clinical Trials, PA
San Antonio, Texas, United States, 78229
United States, Washington
Dermatology Associates
Seattle, Washington, United States, 98101
Canada, Ontario
Mediprobe Research Inc
London, Ontario, Canada, N5X 2P1
Sponsors and Collaborators
PathoLase, Inc.
Layout table for investigator information
Study Director: David M Harris, PhD PathoLase, Inc.
Principal Investigator: Bernard Goffe, MD Dermatology Associates
Layout table for additonal information
Responsible Party: David M Harris, PhD, PathoLase, Inc
ClinicalTrials.gov Identifier: NCT00935649    
Other Study ID Numbers: CLN0001.p.A
First Posted: July 9, 2009    Key Record Dates
Results First Posted: April 9, 2013
Last Update Posted: April 9, 2013
Last Verified: November 2010
Keywords provided by PathoLase, Inc.:
Toenail Fungus
Fungal nails
Additional relevant MeSH terms:
Layout table for MeSH terms
Bacterial Infections and Mycoses
Skin Diseases, Infectious
Nail Diseases
Skin Diseases